Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marcos de Lima
Observed name:
Marcos De Lima
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
University Hospitals Cleveland Medical Center,
University Hospitals Seidman Cancer Center,
The Ohio State University
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
University Hospitals Cleveland Medical Center,
University Hospitals Seidman Cancer Center,
The Ohio State University
ORCID:
0000-0002-8568-4522
Observed ORCID:
0000-0002-8568-4522
OpenAlex ID:
A5124909190
Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies
2026
·
Elvira Umyarova
, John Sharp
, et al.
·
Blood Cancer Journal
·
4
PDF
Spatial tissue analysis of secondary sarcoma following CAR T cell therapy for B cell lymphoma
2026
·
Jia-Jye Lee
, Peirong Hu
, et al.
·
iScience
First Report of Successful, Lifesaving and Timely Graft Rescue Using an Off-the-Shelf Cryopreserved, Cadaveric Marrow in Myeloablative Transplant Following the Unexpected Unavailability of a Living Matched Unrelated Donor.
2026
·
Sumithira Vasu
, Sarah Wall
, et al.
·
Transplantation and Cellular Therapy
Permissive Cardiotoxicity: Real World Outcomes of CAR-T Therapy in Patients with Heart Failure and Reduced Ejection Fraction
2026
·
Sree Maunika Lanka
, Sayan Mullick Chowdhury
, et al.
·
Transplantation and Cellular Therapy
Real World Experience of Alpha-1 Antitrypsin in Treatment-Refractory Acute Graft Versus Host Disease: High Durable Response Rate
2026
·
Henry Hildorf Castellani
, Jean Caputo
, et al.
·
Transplantation and Cellular Therapy
Reduced Dose Post-Transplant Cyclophosphamide in Allogeneic Hematopoietic Cell Transplant
2026
·
Lauren Scarpetti
, Qiuhong Zhao
, et al.
·
Transplantation and Cellular Therapy
Impact of Infusion Timing on Safety and Efficacy of Anti-CD19 and Anti-BCMA CAR T Therapies
2026
·
Sidharth Iyer
, Timothy Voorhees
, et al.
·
Transplantation and Cellular Therapy
High Rates of Chronic GVHD Flares after Ruxolitinib Taper or Discontinuation
2026
·
Jean Caputo
, Marcus Skinner
, et al.
·
Transplantation and Cellular Therapy
Safety and Immunomodulatory Effects of Siltuximab Prophylaxis Prior to Standard of Care CD19 Directed Chimeric Antigen Receptor T-cell (CD19.CART) Therapy for B-cell Lymphomas: Final Phase I Trial Results
2026
·
Nathan Denlinger
, NoJoon Song
, et al.
·
Transplantation and Cellular Therapy
Anti-CD19 Chimeric Antigen Receptor T-cell Therapy for Patients with Non-Hodgkin's Lymphoma and Concurrent Autoimmune Disease
2026
·
Zachary Braunstein
, Zeynep Ozgur
, et al.
·
Transplantation and Cellular Therapy
Identifying and Treating Genitourinary GVHD: Advancing Detection amidst Gaps in Assessment Tools
2026
·
Jean Caputo
, Brittany Knauss
, et al.
·
Transplantation and Cellular Therapy
Sustained Expansion of CAR-Negative T cells Correlates with Improved Outcomes after CD19 CAR T-cell Therapy in Lymphoma
2026
·
Jiasheng Wang
, Tuan Phan
, et al.
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
12
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type